InspireMD, Inc. , the leader in embolic protection stents, today announced a robust schedule of educational events and data presentations at EuroPCR, culminating in the first presentation of 6-month results from the MASTER trial of the Company's MGuard Embolic Protection Stent .
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-to-Announce-Six-Month-Results-from-the-M/ArticleNewsFeed/Article/detail/813492?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-to-Announce-Six-Month-Results-from-the-M/ArticleNewsFeed/Article/detail/813492?ref=25
No comments:
Post a Comment